{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:17:07Z","timestamp":1788448627375,"version":"build-2803163510"},"reference-count":189,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004006","name":"\u0130stanbul \u00dcniversitesi Bilimsel Ara\u015ft\u0131rma Projeleri Birimi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.imlet.2026.107226","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:05:48Z","timestamp":1786374348000},"page":"107226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Innate lymphoid cells: Bridging basic biology and disease"],"prefix":"10.1016","volume":"283","author":[{"given":"Metin Yusuf","family":"Gelmez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7994-5618","authenticated-orcid":false,"given":"Fatma Betul","family":"Oktelik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5596-9746","authenticated-orcid":false,"given":"Aysenur","family":"Kokoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3449-5868","authenticated-orcid":false,"given":"Semra","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8330-7010","authenticated-orcid":false,"given":"Suzan","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0721-6213","authenticated-orcid":false,"given":"Gunnur","family":"Deniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0001","doi-asserted-by":"crossref","first-page":"10","DOI":"10.21911\/aai.313","article-title":"How the innate lymphoid cells improved our understanding of the mechanisms of allergic diseases and influenced the standpoint?","volume":"22","author":"Gelmez","year":"2024","journal-title":"Asthma Allergy Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2026.107226_bib0002","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1074-7613(00)80371-4","article-title":"Developing lymph nodes collect CD4+CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells","volume":"7","author":"Mebius","year":"1997","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.imlet.2026.107226_bib0003","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/eji.201040851","article-title":"Lymphotoxin-beta receptor-independent development of intestinal IL-22-producing NKp46+ innate lymphoid cells","volume":"41","author":"Satoh-Takayama","year":"2011","journal-title":"Eur. J. Immunol."},{"issue":"7280","key":"10.1016\/j.imlet.2026.107226_bib0004","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature08636","article-title":"Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells","volume":"463","author":"Moro","year":"2010","journal-title":"Nature"},{"issue":"7293","key":"10.1016\/j.imlet.2026.107226_bib0005","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nature08900","article-title":"Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity","volume":"464","author":"Neill","year":"2010","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.imlet.2026.107226_bib0006","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.immuni.2008.11.001","article-title":"Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense","volume":"29","author":"Satoh-Takayama","year":"2008","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.imlet.2026.107226_bib0007","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.it.2025.01.009","article-title":"Helper ILCs in the human hematopoietic system","volume":"46","author":"Su","year":"2025","journal-title":"Trends. Immunol."},{"key":"10.1016\/j.imlet.2026.107226_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2021.04.008","article-title":"Inflammatory status might direct ILC and NK cells to IL-17 expressing ILC3 and NK subsets in Behcet's disease","volume":"235","author":"Gelmez","year":"2021","journal-title":"Immunol. Lett."},{"issue":"3","key":"10.1016\/j.imlet.2026.107226_bib0009","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jaci.2024.06.016","article-title":"Circulating innate lymphoid cells (cILCs): unconventional lymphocytes with hidden talents","volume":"154","author":"Bennstein","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"issue":"9","key":"10.1016\/j.imlet.2026.107226_bib0010","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s12276-023-01022-z","article-title":"Versatile roles of innate lymphoid cells at the mucosal barrier: from homeostasis to pathological inflammation","volume":"55","author":"Ryu","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.imlet.2026.107226_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.803563","article-title":"The role of innate lymphoid cells in cancer development and immunotherapy","volume":"10","author":"Sugimura","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.imlet.2026.107226_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1317522","article-title":"A novel type-2 innate lymphoid cell-based immunotherapy for cancer","volume":"15","author":"Saranchova","year":"2024","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2026.107226_bib0013","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.immuni.2020.12.013","article-title":"Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response","volume":"54","author":"Golebski","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2026.107226_bib0014","article-title":"Innate lymphoid cells in autoimmune diseases","volume":"12","author":"Clottu","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2026.107226_bib0015","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jaci.2021.03.009","article-title":"Innate lymphoid cell development","volume":"147","author":"Ghaedi","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2026.107226_bib0016","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.immuni.2014.01.012","article-title":"The transcription factor GATA3 is critical for the development of all IL-7Ralpha-expressing innate lymphoid cells","volume":"40","author":"Yagi","year":"2014","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.imlet.2026.107226_bib0017","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tcb.2023.06.007","article-title":"Development of the hematopoietic system: expanding the concept of hematopoietic stem cell-independent hematopoiesis","volume":"34","author":"Yokomizo","year":"2024","journal-title":"Trends. Cell Biol."},{"issue":"19","key":"10.1016\/j.imlet.2026.107226_bib0018","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1016\/j.devcel.2024.06.010","article-title":"Human yolk sac-derived innate lymphoid-biased multipotent progenitors emerge prior to hematopoietic stem cell formation","volume":"59","author":"Ni","year":"2024","journal-title":"Dev. Cell"},{"issue":"2","key":"10.1016\/j.imlet.2026.107226_bib0019","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells-a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2026.107226_bib0020","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.imlet.2026.107226_bib0021","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.immuni.2013.02.010","article-title":"Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells","volume":"38","author":"Fuchs","year":"2013","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.imlet.2026.107226_bib0022","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1084\/jem.20131560","article-title":"T-bet and eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow","volume":"211","author":"Daussy","year":"2014","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.imlet.2026.107226_bib0023","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.cell.2014.03.030","article-title":"Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages","volume":"157","author":"Klose","year":"2014","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.imlet.2026.107226_bib0024","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202149435","article-title":"ILC1: development, maturation, and transcriptional regulation","volume":"53","author":"Taggenbrock","year":"2023","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2026.107226_bib0025","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/ibd\/izaa316","article-title":"Crohn's disease is associated with activation of circulating innate lymphoid cells","volume":"27","author":"Mazzurana","year":"2021","journal-title":"Inflamm. Bowel. Dis."},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0026","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41598-019-57233-w","article-title":"Role of innate lymphoid cells in chronic colitis during anti-IL-17A therapy","volume":"10","author":"Park","year":"2020","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.imlet.2026.107226_bib0027","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.diabet.2018.08.005","article-title":"Type 1 innate lymphoid cells are associated with type 2 diabetes","volume":"45","author":"Liu","year":"2019","journal-title":"Diabetes Metab."},{"issue":"3","key":"10.1016\/j.imlet.2026.107226_bib0028","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4274\/tji.galenos.2021.69885","article-title":"Friend or foe? The potential roles of innate lymphoid cells in lung transplantation","volume":"9","author":"Bulut","year":"2021","journal-title":"Turk. J. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0029","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1164\/rccm.201906-1113OC","article-title":"Lung innate lymphoid cell composition is altered in primary graft dysfunction","volume":"201","author":"Monticelli","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"25","key":"10.1016\/j.imlet.2026.107226_bib0030","doi-asserted-by":"crossref","first-page":"11489","DOI":"10.1073\/pnas.1003988107","article-title":"Systemically dispersed innate IL-13-expressing cells in type 2 immunity","volume":"107","author":"Price","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.imlet.2026.107226_bib0031","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ni.2104","article-title":"Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161","volume":"12","author":"Mjosberg","year":"2011","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2026.107226_bib0032","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.immuni.2012.08.015","article-title":"The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells","volume":"37","author":"Mjosberg","year":"2012","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.imlet.2026.107226_bib0033","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni.2208","article-title":"Transcription factor RORalpha is critical for nuocyte development","volume":"13","author":"Wong","year":"2012","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2026.107226_bib0034","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/eji.201848006","article-title":"Expression of c-Kit discriminates between two functionally distinct subsets of human type 2 innate lymphoid cells","volume":"49","author":"Hochdorfer","year":"2019","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.imlet.2026.107226_bib0035","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/s41590-019-0423-0","article-title":"c-kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies","volume":"20","author":"Bernink","year":"2019","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2026.107226_bib0036","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12265","article-title":"Interleukin-33 increases type 2 innate lymphoid cell count and their activation in eosinophilic asthma","volume":"13","author":"Sun","year":"2023","journal-title":"Clin. Transl. Allergy"},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0037","doi-asserted-by":"crossref","DOI":"10.1111\/imr.70036","article-title":"ILC2 diversity, location, and function in pulmonary disease","volume":"332","author":"Verma","year":"2025","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.imlet.2026.107226_bib0038","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.immuni.2020.02.009","article-title":"Interleukin-33 induces the enzyme tryptophan hydroxylase 1 to promote inflammatory group 2 innate lymphoid cell-mediated immunity","volume":"52","author":"Flamar","year":"2020","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.imlet.2026.107226_bib0039","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ni.3078","article-title":"IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential 'inflammatory' type 2 innate lymphoid cells","volume":"16","author":"Huang","year":"2015","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2026.107226_bib0040","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.immuni.2014.11.010","article-title":"Human RORgammat(+)CD34(+) cells are lineage-specified progenitors of group 3 RORgammat(+) innate lymphoid cells","volume":"41","author":"Montaldo","year":"2014","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.imlet.2026.107226_bib0041","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1084\/jem.20190490","article-title":"KLRG1 and NKp46 discriminate subpopulations of human CD117(+)CRTH2(-) ILCs biased toward ILC2 or ILC3","volume":"216","author":"Nagasawa","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2026.107226_bib0042","article-title":"MHC class II of different non-professional antigen-presenting cells mediate multiple effects of crosstalk with CD4(+)T cells in lung diseases","volume":"12","author":"Wang","year":"2025","journal-title":"Front. Med. (Lausanne)"},{"issue":"4","key":"10.1016\/j.imlet.2026.107226_bib0043","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/eji.202048696","article-title":"Identification of human cytotoxic ILC3s","volume":"51","author":"Krabbendam","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imlet.2026.107226_bib0044","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.coi.2020.08.007","article-title":"Innate lymphoid cells: from helper to killer","volume":"68","author":"Krabbendam","year":"2021","journal-title":"Curr. Opin. Immunol."},{"issue":"27","key":"10.1016\/j.imlet.2026.107226_bib0045","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1182\/bloodadvances.2017008839","article-title":"Interleukins 12 and 15 induce cytotoxicity and early NK-cell differentiation in type 3 innate lymphoid cells","volume":"1","author":"Raykova","year":"2017","journal-title":"Blood Adv."},{"issue":"70","key":"10.1016\/j.imlet.2026.107226_bib0046","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi8642","article-title":"Cytotoxic granzyme C-expressing ILC1s contribute to antitumor immunity and neonatal autoimmunity","volume":"7","author":"Nixon","year":"2022","journal-title":"Sci. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2026.107226_bib0047","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41590-022-01213-2","article-title":"Cytotoxic innate lymphoid cells sense cancer cell-expressed interleukin-15 to suppress human and murine malignancies","volume":"23","author":"Kansler","year":"2022","journal-title":"Nat. Immunol."},{"issue":"70","key":"10.1016\/j.imlet.2026.107226_bib0048","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abo2159","article-title":"ILC killer: qu'est-ce que c'est?","volume":"7","author":"Withers","year":"2022","journal-title":"Sci. Immunol."},{"issue":"10","key":"10.1016\/j.imlet.2026.107226_bib0049","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41590-021-01013-0","article-title":"Effector differentiation downstream of lineage commitment in ILC1s is driven by Hobit across tissues","volume":"22","author":"Friedrich","year":"2021","journal-title":"Nat. Immunol."},{"issue":"75","key":"10.1016\/j.imlet.2026.107226_bib0050","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abo6641","article-title":"Embryonic and neonatal waves generate distinct populations of hepatic ILC1s","volume":"7","author":"Sparano","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.imlet.2026.107226_bib0051","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.84209","article-title":"Liver type 1 innate lymphoid cells lacking IL-7 receptor are a native killer cell subset fostered by parenchymal niches","volume":"12","author":"Asahi","year":"2023","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0052","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cell.2017.07.027","article-title":"Regulatory innate lymphoid cells control innate intestinal inflammation","volume":"171","author":"Wang","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0053","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/s41467-017-02023-z","article-title":"Alternative activation generates IL-10 producing type 2 innate lymphoid cells","volume":"8","author":"Seehus","year":"2017","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.imlet.2026.107226_bib0054","doi-asserted-by":"crossref","first-page":"293","DOI":"10.5483\/BMBRep.2016.49.5.023","article-title":"A novel IL-10-producing innate lymphoid cells (ILC10) in a contact hypersensitivity mouse model","volume":"49","author":"Kim","year":"2016","journal-title":"BMB Rep."},{"issue":"6","key":"10.1016\/j.imlet.2026.107226_bib0055","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.jaci.2018.12.1018","article-title":"Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid","volume":"143","author":"Morita","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2026.107226_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2024.578489","article-title":"Retinoic acid modulates peripheral blood helper innate lymphoid cell composition in vitro in patients with multiple sclerosis","volume":"398","author":"Ozkosar","year":"2025","journal-title":"J. Neuroimmunol."},{"issue":"9","key":"10.1016\/j.imlet.2026.107226_bib0057","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/eji.202049033","article-title":"Innate lymphoid cells and cancer: role in tumor progression and inhibition","volume":"51","author":"Yuan","year":"2021","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0058","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12885-018-4262-4","article-title":"Activated innate lymphoid cell populations accumulate in human tumour tissues","volume":"18","author":"Salimi","year":"2018","journal-title":"BMC. Cancer"},{"key":"10.1016\/j.imlet.2026.107226_bib0059","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.3389\/fimmu.2019.02121","article-title":"Peripheral innate lymphoid cells are increased in first line metastatic colorectal carcinoma patients: a negative correlation with Th1 immune responses","volume":"10","author":"Loyon","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2026.107226_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/923135","article-title":"Polarization of ILC2s in peripheral blood might contribute to immunosuppressive microenvironment in patients with gastric cancer","volume":"2014","author":"Bie","year":"2014","journal-title":"J. Immunol. Res."},{"issue":"8","key":"10.1016\/j.imlet.2026.107226_bib0061","article-title":"Single-cell transcriptomic landscape reveals tumor specific innate lymphoid cells associated with colorectal cancer progression","volume":"2","author":"Qi","year":"2021","journal-title":"Cell Rep. Med."},{"issue":"11","key":"10.1016\/j.imlet.2026.107226_bib0062","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.3324\/haematol.2016.144725","article-title":"Innate lymphoid cells are expanded and functionally altered in chronic lymphocytic leukemia","volume":"101","author":"de Weerdt","year":"2016","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0063","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1038\/s41598-018-20608-6","article-title":"Type 2 innate lymphocytes actuate immunity against tumours and limit cancer metastasis","volume":"8","author":"Saranchova","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0064","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1186\/s12967-023-04418-7","article-title":"Eosinophils in the tumor microenvironment: implications for cancer immunotherapy","volume":"21","author":"Ghaffari","year":"2023","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.imlet.2026.107226_bib0065","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4049\/jimmunol.1101270","article-title":"Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunity","volume":"188","author":"Ikutani","year":"2012","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2026.107226_bib0066","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ccell.2022.01.003","article-title":"Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer","volume":"40","author":"Alam","year":"2022","journal-title":"Cancer Cell."},{"issue":"7","key":"10.1016\/j.imlet.2026.107226_bib0067","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/ijc.28481","article-title":"Interleukin-33\/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells","volume":"134","author":"Jovanovic","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0068","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/imcb.12390","article-title":"Systemic administration of IL-33 induces a population of circulating KLRG1(hi) type 2 innate lymphoid cells and inhibits type 1 innate immunity against multiple myeloma","volume":"99","author":"Guillerey","year":"2021","journal-title":"Immunol. Cell Biol."},{"issue":"3","key":"10.1016\/j.imlet.2026.107226_bib0069","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.pan.2018.02.014","article-title":"Diverse effects of interleukin-22 on pancreatic diseases","volume":"18","author":"Xuan","year":"2018","journal-title":"Pancreatology"},{"key":"10.1016\/j.imlet.2026.107226_bib0070","doi-asserted-by":"crossref","first-page":"8280","DOI":"10.1038\/ncomms9280","article-title":"NCR(+) ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures","volume":"6","author":"Carrega","year":"2015","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.imlet.2026.107226_bib0071","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2249.2012.04570.x","article-title":"Pro-tumour activity of interleukin-22 in HPAFII human pancreatic cancer cells","volume":"168","author":"Curd","year":"2012","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2026.107226_bib0072","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s12094-019-02160-5","article-title":"ILC3 cells promote the proliferation and invasion of pancreatic cancer cells through IL-22\/AKT signaling","volume":"22","author":"Xuan","year":"2020","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.imlet.2026.107226_bib0073","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu-13-886520","article-title":"Plasticity of innate lymphoid cells in cancer","volume":"13","author":"Heinrich","year":"2022","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.imlet.2026.107226_bib0074","doi-asserted-by":"crossref","DOI":"10.1002\/eji.70041","article-title":"Cellular cosmetics: how innate lymphoid cells can recontour the tumour microenvironment","volume":"55","author":"Pun","year":"2025","journal-title":"Eur. J. Immunol."},{"issue":"22","key":"10.1016\/j.imlet.2026.107226_bib0075","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1182\/bloodadvances.2018030478","article-title":"CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML","volume":"3","author":"Salome","year":"2019","journal-title":"Blood Adv."},{"issue":"7","key":"10.1016\/j.imlet.2026.107226_bib0076","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41422-020-0312-y","article-title":"Transdifferentiation of tumor infiltrating innate lymphoid cells during progression of colorectal cancer","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"issue":"7797","key":"10.1016\/j.imlet.2026.107226_bib0077","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-020-2015-4","article-title":"ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity","volume":"579","author":"Moral","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.imlet.2026.107226_bib0078","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cell.2017.09.052","article-title":"ILC1 confer early host protection at initial sites of viral infection","volume":"171","author":"Weizman","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2026.107226_bib0079","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3389\/fimmu.2018.00505","article-title":"Influenza-activated ILC1s contribute to antiviral immunity partially influenced by differential GITR expression","volume":"9","author":"Vashist","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2026.107226_bib0080","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.immuni.2018.05.013","article-title":"Innate lymphoid cells: diversity, plasticity, and unique functions in immunity","volume":"48","author":"Colonna","year":"2018","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.imlet.2026.107226_bib0081","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ni.2131","article-title":"Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus","volume":"12","author":"Monticelli","year":"2011","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0082","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/mi.2017.41","article-title":"IFN-gamma increases susceptibility to influenza A infection through suppression of group II innate lymphoid cells","volume":"11","author":"Califano","year":"2018","journal-title":"Mucosal. Immunol."},{"issue":"11","key":"10.1016\/j.imlet.2026.107226_bib0083","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1164\/rccm.201812-2366OC","article-title":"Elevated levels of type 2 respiratory innate lymphoid cells in human infants with severe respiratory syncytial virus bronchiolitis","volume":"200","author":"Vu","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.imlet.2026.107226_bib0084","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110715","article-title":"ILC precursors differentiate into metabolically distinct ILC1-like cells during Mycobacterium tuberculosis infection","volume":"39","author":"Corral","year":"2022","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.imlet.2026.107226_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008140","article-title":"IL-22 produced by type 3 innate lymphoid cells (ILC3s) reduces the mortality of type 2 diabetes mellitus (T2DM) mice infected with mycobacterium tuberculosis","volume":"15","author":"Tripathi","year":"2019","journal-title":"PLoS. Pathog."},{"issue":"3","key":"10.1016\/j.imlet.2026.107226_bib0086","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/infdis\/jiu106","article-title":"Activation of type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during streptococcus pneumoniae infection","volume":"210","author":"Van Maele","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.imlet.2026.107226_bib0087","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.3390\/ijms21041350","article-title":"Group 2 innate lymphoid cells: central players in a recurring theme of repair and regeneration","volume":"21","author":"Messing","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.imlet.2026.107226_bib0088","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.3390\/ijms20092276","article-title":"Group 2 innate lymphoid cells (ILC2): type 2 immunity and helminth immunity","volume":"20","author":"Herbert","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.imlet.2026.107226_bib0089","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ni.3489","article-title":"Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis","volume":"17","author":"Klose","year":"2016","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2026.107226_bib0090","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jaci.2016.09.006","article-title":"Immune modules shared by innate lymphoid cells and T cells","volume":"138","author":"Robinette","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2026.107226_bib0091","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.imlet.2026.107226_bib0092","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/annrheumdis-2015-207388","article-title":"Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis","volume":"75","author":"Wohlfahrt","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.imlet.2026.107226_bib0093","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1165\/ajrcmb.26.4.4784","article-title":"Interleukin-4- and interleukin-13-enhanced transforming growth factor-beta2 production in cultured human bronchial epithelial cells is attenuated by interferon-gamma","volume":"26","author":"Wen","year":"2002","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0094","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41467-019-13734-w","article-title":"TGF-beta induces ST2 and programs ILC2 development","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.imlet.2026.107226_bib0095","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4049\/jimmunol.1501491","article-title":"CD4+ Group 1 innate lymphoid cells (ILC) form a functionally distinct ILC subset that is increased in systemic sclerosis","volume":"196","author":"Roan","year":"2016","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2026.107226_bib0096","doi-asserted-by":"crossref","DOI":"10.4110\/in.2025.25.e40","article-title":"Tissue-resident ILC2s across organs: heterogeneity, niche crosstalk, and shared regulatory circuits","volume":"25","author":"Kim","year":"2025","journal-title":"Immune Netw."},{"issue":"11","key":"10.1016\/j.imlet.2026.107226_bib0097","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.immuni.2025.09.007","article-title":"Notch3 destabilizes regulatory T cells to drive autoimmune neuroinflammation in multiple sclerosis","volume":"58","author":"Benamar","year":"2025","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.imlet.2026.107226_bib0098","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s13760-020-01518-9","article-title":"Expression of Akt1 and p-Akt1 in peripheral T cell subsets of multiple sclerosis patients","volume":"121","author":"Oktelik","year":"2021","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.imlet.2026.107226_bib0099","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.657622","article-title":"ILC3, a central innate immune component of the gut-brain axis in multiple sclerosis","volume":"12","author":"Miljkovic","year":"2021","journal-title":"Front. Immunol."},{"issue":"7752","key":"10.1016\/j.imlet.2026.107226_bib0100","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-019-1082-x","article-title":"Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2","volume":"568","author":"Zhou","year":"2019","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.imlet.2026.107226_bib0101","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2019.09.014","article-title":"Metabolite-sensing receptor Ffar2 regulates colonic group 3 innate lymphoid cells and gut immunity","volume":"51","author":"Chun","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2026.107226_bib0102","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.653560","article-title":"Modulation of intestinal ILC3 for the treatment of type 1 diabetes","volume":"12","author":"Stojanovic","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2026.107226_bib0103","first-page":"679","article-title":"Intestinal epithelial cell regulation of adaptive immune dysfunction in human type 1 diabetes","volume":"7","author":"Graves","year":"2016","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2026.107226_bib0104","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41584-026-01375-5","article-title":"Innate lymphoid cells in rheumatoid arthritis as mediators of pathology and resolution","volume":"22","author":"Kabil","year":"2026","journal-title":"Nat. Rev. Rheumatol."},{"issue":"20","key":"10.1016\/j.imlet.2026.107226_bib0105","doi-asserted-by":"crossref","first-page":"9867","DOI":"10.3390\/ijms26209867","article-title":"Cellular immunity in obesity: pathophysiological insights and the impact of bariatric surgery","volume":"26","author":"Rivera-Carranza","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.imlet.2026.107226_bib0106","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41577-021-00635-7","article-title":"Immune and non-immune functions of adipose tissue leukocytes","volume":"22","author":"Trim","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"7542","key":"10.1016\/j.imlet.2026.107226_bib0107","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature14115","article-title":"Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity","volume":"519","author":"Brestoff","year":"2015","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.imlet.2026.107226_bib0108","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20121964","article-title":"Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages","volume":"210","author":"Molofsky","year":"2013","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.imlet.2026.107226_bib0109","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.immuni.2017.01.008","article-title":"Adipose type one innate lymphoid cells regulate macrophage homeostasis through targeted cytotoxicity","volume":"46","author":"Boulenouar","year":"2017","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.imlet.2026.107226_bib0110","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.immuni.2017.10.015","article-title":"Interleukin-33-activated islet-resident innate lymphoid cells promote insulin secretion through myeloid cell retinoic acid production","volume":"47","author":"Dalmas","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2026.107226_bib0111","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.imlet.2016.09.007","article-title":"Innate lymphoid cells type 2 - emerging immune regulators of obesity and atherosclerosis","volume":"179","author":"Chalubinski","year":"2016","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imlet.2026.107226_bib0112","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejphar.2017.04.030","article-title":"Innate lymphoid cells in atherosclerosis","volume":"816","author":"Engelbertsen","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.imlet.2026.107226_bib0113","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.immuni.2016.06.016","article-title":"Adipose-resident group 1 innate lymphoid cells promote obesity-associated insulin resistance","volume":"45","author":"O'Sullivan","year":"2016","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.imlet.2026.107226_bib0114","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cmet.2016.03.002","article-title":"Adipose natural killer cells regulate adipose tissue macrophages to promote insulin resistance in obesity","volume":"23","author":"Lee","year":"2016","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.imlet.2026.107226_bib0115","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0028-3908(89)90115-9","article-title":"Characterisation of kappa-opioid binding sites in rat and guinea-pig spinal cord","volume":"28","author":"Wood","year":"1989","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0116","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1038\/s41467-019-11270-1","article-title":"Adipose group 1 innate lymphoid cells promote adipose tissue fibrosis and diabetes in obesity","volume":"10","author":"Wang","year":"2019","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.imlet.2026.107226_bib0117","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/s41366-021-00826-1","article-title":"IFNgamma-producing NK cells in adipose tissue are associated with hyperglycemia and insulin resistance in obese women","volume":"45","author":"Mogilenko","year":"2021","journal-title":"Int. J. Obes. (L.)"},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0118","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.immuni.2019.11.004","article-title":"Type 1 innate lymphoid cells protect mice from acute liver injury via interferon-gamma secretion for upregulating bcl-xL expression in hepatocytes","volume":"52","author":"Nabekura","year":"2020","journal-title":"Immunity"},{"issue":"61","key":"10.1016\/j.imlet.2026.107226_bib0119","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg9698","article-title":"The chemerin-CMKLR1 axis limits thermogenesis by controlling a beige adipocyte\/IL-33\/type 2 innate immunity circuit","volume":"6","author":"Lin","year":"2021","journal-title":"Sci. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2026.107226_bib0120","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41590-021-00922-4","article-title":"Single-cell sequencing of human white adipose tissue identifies new cell states in health and obesity","volume":"22","author":"Hildreth","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2026.107226_bib0121","article-title":"Role of innate lymphoid cells in obesity and insulin resistance","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"7583","key":"10.1016\/j.imlet.2026.107226_bib0122","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nature16460","article-title":"Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration","volume":"528","author":"Lindemans","year":"2015","journal-title":"Nature"},{"issue":"7743","key":"10.1016\/j.imlet.2026.107226_bib0123","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41586-019-0899-7","article-title":"Interleukin-22 protects intestinal stem cells against genotoxic stress","volume":"566","author":"Gronke","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2026.107226_bib0124","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.648754","article-title":"Group 3 innate lymphoid cells protect steatohepatitis from high-fat diet induced toxicity","volume":"12","author":"Hamaguchi","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2026.107226_bib0125","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s42255-021-00371-1","article-title":"Inhibition of the IL-17A axis in adipocytes suppresses diet-induced obesity and metabolic disorders in mice","volume":"3","author":"Teijeiro","year":"2021","journal-title":"Nat. Metab."},{"issue":"12","key":"10.1016\/j.imlet.2026.107226_bib0126","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1161\/ATVBAHA.115.306048","article-title":"Expansion of CD25+ innate lymphoid cells reduces atherosclerosis","volume":"35","author":"Engelbertsen","year":"2015","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"10.1016\/j.imlet.2026.107226_bib0127","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1354617","article-title":"Enrichment of type 1 innate lymphoid cells in the course of human atherosclerotic plaque development suggests contribution to atherogenesis","volume":"15","author":"Pertiwi","year":"2024","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2026.107226_bib0128","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/01.ATV.0000059419.11002.6E","article-title":"Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse","volume":"23","author":"Buono","year":"2003","journal-title":"Arter. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.imlet.2026.107226_bib0129","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1073\/pnas.0409015102","article-title":"T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses","volume":"102","author":"Buono","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.imlet.2026.107226_bib0130","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0002-9440(10)63471-2","article-title":"The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice","volume":"163","author":"Davenport","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.imlet.2026.107226_bib0131","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/CIRCRESAHA.111.261784","article-title":"The IL-17A\/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment","volume":"110","author":"Butcher","year":"2012","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.imlet.2026.107226_bib0132","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/ATVBAHA.111.229997","article-title":"Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice","volume":"32","author":"Danzaki","year":"2012","journal-title":"Arter. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.imlet.2026.107226_bib0133","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.atherosclerosis.2015.08.006","article-title":"IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout mice","volume":"242","author":"Rattik","year":"2015","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0134","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/all.70030","article-title":"The expanding role of ILC2s in allergic airways disease","volume":"81","author":"Cain","year":"2026","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.imlet.2026.107226_bib0135","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.immuni.2019.02.002","article-title":"Adventitial stromal cells define group 2 innate lymphoid cell tissue niches","volume":"50","author":"Dahlgren","year":"2019","journal-title":"Immunity"},{"issue":"36","key":"10.1016\/j.imlet.2026.107226_bib0136","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aav7638","article-title":"Pulmonary environmental cues drive group 2 innate lymphoid cell dynamics in mice and humans","volume":"4","author":"Puttur","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.imlet.2026.107226_bib0137","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fmed.2017.00093","article-title":"The biology of eosinophils and their role in asthma","volume":"4","author":"McBrien","year":"2017","journal-title":"Front. Med. (Lausanne)"},{"issue":"11","key":"10.1016\/j.imlet.2026.107226_bib0138","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1182\/blood.V79.11.2952.bloodjournal79112952","article-title":"Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects","volume":"79","author":"Sehmi","year":"1992","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.imlet.2026.107226_bib0139","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11882-013-0373-9","article-title":"Role of interleukin-13 in asthma","volume":"13","author":"Corren","year":"2013","journal-title":"Curr. Allergy Asthma Rep."},{"issue":"3","key":"10.1016\/j.imlet.2026.107226_bib0140","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jaci.2016.06.032","article-title":"Human circulating group 2 innate lymphoid cells can express CD154 and promote IgE production","volume":"139","author":"Maggi","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2026.107226_bib0141","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.3892\/mmr.2017.6500","article-title":"Simultaneously increased expression of glucocorticoid\u2011induced tumor necrosis factor receptor and its ligand contributes to increased interleukin\u20115\/13\u2011producing group 2 innate lymphocytes in murine asthma","volume":"15","author":"Zhang","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"8","key":"10.1016\/j.imlet.2026.107226_bib0142","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1164\/rccm.201909-1722OC","article-title":"The role of the TL1A\/DR3 axis in the activation of group 2 innate lymphoid cells in subjects with eosinophilic asthma","volume":"202","author":"Machida","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0143","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1038\/s41467-020-17813-1","article-title":"PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity","volume":"11","author":"Helou","year":"2020","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.imlet.2026.107226_bib0144","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/s41423-024-01208-z","article-title":"SIRPalpha engagement regulates ILC2 effector function and alleviates airway hyperreactivity via modulating energy metabolism","volume":"21","author":"Sakano","year":"2024","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.imlet.2026.107226_bib0145","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3389\/fimmu.2020.01793","article-title":"Leukocyte associated immunoglobulin like receptor 1 regulation and function on monocytes and dendritic cells during inflammation","volume":"11","author":"Carvalheiro","year":"2020","journal-title":"Front. Immunol."},{"issue":"21","key":"10.1016\/j.imlet.2026.107226_bib0146","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.3390\/cells12212556","article-title":"Regulatory ILC2-role of IL-10 producing ILC2 in asthma","volume":"12","author":"Fard","year":"2023","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.imlet.2026.107226_bib0147","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/ni.3444","article-title":"IL-1beta, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs","volume":"17","author":"Bal","year":"2016","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0148","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1038\/s41467-019-09883-7","article-title":"IL-1beta, IL-23, and TGF-beta drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation","volume":"10","author":"Golebski","year":"2019","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.imlet.2026.107226_bib0149","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1164\/rccm.202311-2164OC","article-title":"Neuromedin-U mediates rapid activation of airway group 2 innate lymphoid cells in mild asthma","volume":"210","author":"Ju","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00726-011-1184-8","article-title":"Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions","volume":"45","author":"Delgado","year":"2013","journal-title":"Amino Acids."},{"issue":"Suppl 5(Suppl 5)","key":"10.1016\/j.imlet.2026.107226_bib0151","doi-asserted-by":"crossref","first-page":"S263","DOI":"10.1513\/AnnalsATS.201403-097AW","article-title":"Type-2 innate lymphoid cells in asthma and allergy","volume":"11","author":"McKenzie","year":"2014","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0152","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/intimm\/dxv050","article-title":"Group 2 innate lymphoid cells in disease","volume":"28","author":"Halim","year":"2016","journal-title":"Int. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2026.107226_bib0153","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/ACI.0000000000001018","article-title":"Innate lymphoid cells in immunoglobulin E-mediated food allergy","volume":"24","author":"Ilangovan","year":"2024","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2026.107226_bib0154","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/intimm\/dxaf071","article-title":"Microniche control of innate lymphocyte biology in the gut","volume":"38","author":"Towers","year":"2026","journal-title":"Int. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0155","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.immuni.2010.12.009","article-title":"CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut","volume":"34","author":"Sonnenberg","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2026.107226_bib0156","article-title":"Crosstalk between the gut microbiota and innate lymphoid cells in intestinal mucosal immunity","volume":"14","author":"Guo","year":"2023","journal-title":"Front. Immunol."},{"issue":"7452","key":"10.1016\/j.imlet.2026.107226_bib0157","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature12240","article-title":"Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria","volume":"498","author":"Hepworth","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0158","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1038\/s41467-022-29734-2","article-title":"Intestinal fibroblastic reticular cell niches control innate lymphoid cell homeostasis and function","volume":"13","author":"Cheng","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0159","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/mi.2013.33","article-title":"IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism","volume":"7","author":"Eken","year":"2014","journal-title":"Mucosal. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2026.107226_bib0160","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ni.2534","article-title":"Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues","volume":"14","author":"Bernink","year":"2013","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0161","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/ecco-jcc\/jjy119","article-title":"Distinct alterations in the composition of mucosal innate lymphoid cells in newly diagnosed and established Crohn's disease and ulcerative colitis","volume":"13","author":"Forkel","year":"2019","journal-title":"J. Crohns. Colitis."},{"key":"10.1016\/j.imlet.2026.107226_bib0162","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.867351","article-title":"Heterogeneity of ILC2s in the intestine; homeostasis and pathology","volume":"13","author":"Sunaga","year":"2022","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.imlet.2026.107226_bib0163","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/resp.14506","article-title":"Severe asthma ILC2s demonstrate enhanced proliferation that is modified by biologics","volume":"28","author":"Malik","year":"2023","journal-title":"Respirology"},{"key":"10.1016\/j.imlet.2026.107226_bib0164","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.930862","article-title":"The therapeutic potential for targeting group 2 innate lymphoid cells in asthma","volume":"13","author":"Matsuyama","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2026.107226_bib0165","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41419-019-1540-2","article-title":"ILC3 function as a double-edged sword in inflammatory bowel diseases","volume":"10","author":"Zeng","year":"2019","journal-title":"Cell Death. Dis."},{"issue":"18","key":"10.1016\/j.imlet.2026.107226_bib0166","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.3390\/ijms21186604","article-title":"Role of innate immune cells in psoriasis","volume":"21","author":"Sato","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.imlet.2026.107226_bib0167","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210172","article-title":"The role of IL-23 in the pathogenesis and therapy of inflammatory bowel disease","volume":"24","author":"Korta","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imlet.2026.107226_bib0168","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.621956","article-title":"Major role of the IL17\/23 axis in psoriasis supports the development of new targeted therapies","volume":"12","author":"Bugaut","year":"2021","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.imlet.2026.107226_bib0169","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/bloodadvances.2016002352","article-title":"IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells","volume":"1","author":"Camelo","year":"2017","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.imlet.2026.107226_bib0170","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3390\/biom13060893","article-title":"The functional role of group 2 innate lymphoid cells in asthma","volume":"13","author":"Matsuyama","year":"2023","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.imlet.2026.107226_bib0171","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1084\/jem.20101712","article-title":"IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease","volume":"208","author":"Geremia","year":"2011","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.imlet.2026.107226_bib0172","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/jid.2013.477","article-title":"Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis","volume":"134","author":"Villanova","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"9","key":"10.1016\/j.imlet.2026.107226_bib0173","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1038\/jid.2014.146","article-title":"Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients","volume":"134","author":"Teunissen","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.imlet.2026.107226_bib0174","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1084\/jem.20122308","article-title":"Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model","volume":"210","author":"Kirchberger","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2026.107226_bib0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.747324","article-title":"Interleukin-7 biology and its effects on immune cells: mediator of generation, differentiation, survival, and homeostasis","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2026.107226_bib0176","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1146077","article-title":"Transcriptional control of ILC identity","volume":"14","author":"Korchagina","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2026.107226_bib0177","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.836999","article-title":"Tissue-dependent adaptations and functions of innate lymphoid cells","volume":"13","author":"Murphy","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0178","first-page":"1","article-title":"Group 2 innate lymphoid cells: new players in human allergic diseases","volume":"25","author":"Doherty","year":"2015","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2026.107226_bib0179","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101563","article-title":"Isolation and adoptive transfer of innate lymphoid cells 2 to a recipient mouse model of PDAC","volume":"3","author":"Alam","year":"2022","journal-title":"STAR. Protoc."},{"issue":"7","key":"10.1016\/j.imlet.2026.107226_bib0180","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20241671","article-title":"Functional targeting of ILC2s and ILC3s reveals selective roles in intestinal fibrosis and homeostasis","volume":"222","author":"Kabil","year":"2025","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.imlet.2026.107226_bib0181","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.cell.2018.10.014","article-title":"Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells","volume":"175","author":"Andre","year":"2018","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.imlet.2026.107226_bib0182","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41590-018-0132-0","article-title":"Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity","volume":"19","author":"Zhang","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2026.107226_bib0183","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.849958","article-title":"Checkpoint inhibitors modulate plasticity of innate lymphoid cells in peripheral blood of patients with hepatocellular carcinoma","volume":"13","author":"Heinrich","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2026.107226_bib0184","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.04.002","article-title":"Helper-like innate lymphoid cells and cancer immunotherapy","volume":"41","author":"Crinier","year":"2019","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2026.107226_bib0185","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41467-017-00678-2","article-title":"Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis","volume":"8","author":"Trabanelli","year":"2017","journal-title":"Nat. Commun."},{"issue":"19","key":"10.1016\/j.imlet.2026.107226_bib0186","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1016\/j.cell.2021.07.029","article-title":"Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer","volume":"184","author":"Goc","year":"2021","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.imlet.2026.107226_bib0187","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/cea.12462","article-title":"Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia","volume":"45","author":"Ho","year":"2015","journal-title":"Clin. Exp. Allergy"},{"issue":"3","key":"10.1016\/j.imlet.2026.107226_bib0188","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/biom14030294","article-title":"TNF superfamily and ILC2 activation in asthma","volume":"14","author":"Matsuyama","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.imlet.2026.107226_bib0189","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.3389\/fimmu.2019.02591","article-title":"Context dependent role of type 2 innate lymphoid cells in allergic skin inflammation","volume":"10","author":"Rafei-Shamsabadi","year":"2019","journal-title":"Front. Immunol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247826001008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247826001008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:31:11Z","timestamp":1788445871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247826001008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":189,"alternative-id":["S0165247826001008"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2026.107226","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innate lymphoid cells: Bridging basic biology and disease","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2026.107226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Federation of Immunological Societies. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107226"}}